PMC:7283670 / 91203-91817
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T487 | 45-53 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T488 | 277-285 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T489 | 429-437 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T772 | 232-238 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | Active |
| T773 | 326-327 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T774 | 348-349 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T376 | 27-32 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T377 | 147-156 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T378 | 167-176 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T379 | 186-191 | Chemical | denotes | alpha | http://purl.obolibrary.org/obo/CHEBI_30216 |
| T380 | 192-202 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T381 | 259-264 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T382 | 287-296 | Chemical | denotes | Lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T383 | 297-306 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T384 | 356-361 | Chemical | denotes | alpha | http://purl.obolibrary.org/obo/CHEBI_30216 |
| T385 | 362-372 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T386 | 413-418 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T387 | 531-540 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T388 | 551-560 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T389 | 570-575 | Chemical | denotes | alpha | http://purl.obolibrary.org/obo/CHEBI_30216 |
| T390 | 576-586 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T784 | 55-231 | Sentence | denotes | Xiyanping injection, 10–20 ml daily, Qd, the maximum daily does not exceed 500 mg (20 ml) + lopinavir tablet or ritonavir tablet + alpha‐interferon nebulization, for 7–14 days, |
| T785 | 232-286 | Sentence | denotes | Active comparator: control group of ordinary COVID‐19: |
| T786 | 287-385 | Sentence | denotes | Lopinavir/ritonavir tablets, two times a day, two tablets at a time; alpha‐interferon nebulization |
| T787 | 386-438 | Sentence | denotes | Experimental: experimental group of severe COVID‐19: |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1863 | 186-225 | Gene | denotes | alpha‐interferon nebulization, for 7–14 | |
| 1864 | 570-609 | Gene | denotes | alpha‐interferon nebulization, for 7–14 | |
| 2082 | 147-156 | Chemical | denotes | lopinavir | MESH:D061466 |
| 2083 | 287-306 | Chemical | denotes | Lopinavir/ritonavir | MESH:C558899 |
| 2084 | 531-540 | Chemical | denotes | lopinavir | MESH:D061466 |